Multifocal choroiditis and panuveitis
Multifocal choroiditis and panuveitis (MCP) is an idiopathic inflammatory disorder of unknown etiology affecting the choroid, retina, and vitreous of the eye that presents asymmetrically, most often in young myopic women with photopsias, enlargement of the physiologic blind spot and decreased vision.
The first description of the disease was written in 1973.[1]
Symptoms
blurry vision with or without sensitivity to light, blind spots, floaters, eye discomfort and perceived flashes of light.[1]
Diagnosis
An ophthalmologist may use a Series of imaging techniques. A test called flourescein angiography uses a special dye and camera to study blood flow in the back layers of the eye. When a person has MFC, lesions in the eye will appear as fluorescent spots. Visual field tests may also show an enlarged blind spot or a decrease in visual clarity. Often, Doctors may order blood tests to check if the symptoms are caused by a viral disease rather than MFC.
Treatment
Treatments vary depending on the severity of the diagnosis. A steroid regiment taken orally, often low doses, is recommended as a first course of treatment. The low dose of Steroids can help decrease inflammation, and as a result, lessens the visual impairment. In the event steroids are not effective , medicines may be administered via injections directly into the eye. One such treatment, Ozurdex. A small capsule is inserted into the eye via injection, and releases medicines slowly, in the course of a few months, as the capsule dissolves.
References
Further reading
- Yanoff, Myron; Duker, Jay S. (2009). Ophthalmology (3rd ed.). Mosby Elsevier. ISBN 978-0-323-04332-8.